Stay in touch
Prime news from our network.
Stay in touch
Prime news from our network.
„The add-on offers training tips based on the medically tested OvulaRing method and is tailored to the respective cycle phase. This enables women to improve their performance, minimise the risk of injury and regenerate better by taking their hormone status into account. In addition, the extension recognises symptoms of an energy deficit or overtraining at an early stage and can thus avoid overloading and maintain the user's fertility.
The new feature is integrated into the OvulaRing app and allows you to easily switch between the fertility and sports view. The add-on was developed in close collaboration with sports scientists and experts in cycle-based training. Tips from these experts on cycle-based running, strength and cycling training as well as nutrition for female athletes are also included in the add-on. This provides users with valuable expertise for their training and recovery.
„With OvulaRing, women can always keep a close eye on their fertile days and cycle health. With the new sport add-on, they now also have the perfect companion for their training with them at all times. The new function is a further step towards promoting health and fertility while achieving sporting goals," says Prof Henry Alexander, inventor of OvulaRing.
The add-on is available in the OvulaRing app for iOS. An update of the Android version will follow in a few weeks.
Üüber die VivoSensMedical GmbHVivoSensMedical's vision is to improve diagnostics for women's health and set new standards in gynaecology, reproductive and sexual medicine. Building on 40 years of medical research, the Leipzig-based company has developed a platform technology for individualised diagnostics based on the biomarker core body temperature and launched its first product in the field of women's health, OvulaRing. OvulaRing is a certified medical device, clinically validated as such and fulfils the strict requirements for quality and data protection. The company was founded in 2011 and is funded by the European Regional Development Fund (ERDF), the Saxon State Ministry of Economic Affairs, Labour and Transport (SMWA), the State Ministry of Science and the Arts (SMWK) and the City of Leipzig. OvulaRing was supported by the Federal Ministry of Economics and Technology as part of an EXIST start-up grant.
More information at: www.ovularing.com / www.vivosensmedical.com
The above texts, or parts thereof, were automatically translated from the original language text using a translation system (DeepL API).
Despite careful machine processing, translation errors cannot be ruled out.